Anti-coagulant therapy in the prevention of venous thrombosis and pulmonary embolism in the spinal cord injury.
A prophylactic regime of subcutaneous low-dose heparin for the 1st month, followed by warfarin for the 2nd and 3rd months after spinal cord injury resulted in a dramatic reduction in the incidence of venous thrombosis and pulmonary embolism.
D000293:Adolescent; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011655:Pulmonary Embolism / Q000150:complications / Q000517:prevention & control*; D013119:Spinal Cord Injuries / Q000150:complications* / Q000175:diagnosis; D013924:Thrombophlebitis / Q000150:complications / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D006493:Heparin